PRGO (perrigo.com) Bozor qiymatining balans qiymatiga nisbati

Perrigo Company PLC (PRGO) kompaniyasining rasmiy ramzlari

Perrigo Company plc (PRGO) rahbariyati hozirda biznesni qayta tuzmoqda va e'tiborni sog'liqni saqlash mahsulotlariga qaratmoqda. Ushbu strategiya asosiy bo'lmagan bo'linmalarni sotish va chaqaloqlar uchun formula logistikasini optimallashtirishni nazarda tutadi. Ishlab chiqarish sikli ichki inshootlarni saqlab qolgan holda tashqi xomashyo yetkazib beruvchilarga tayanadi va joriy ko'rsatkich 0.89 ni tashkil etadi. GURU.Markets platformasidagi tarixiy narxlar dinamikasi ushbu o'zgarishlarga bozorning qanday munosabatda bo'lganini aniq ko'rsatadi.

PRGO Perrigo Corp: Balans qiymatiga nisbatan bozor qiymati 04.07.2022 - 28.10.2026 oraligʻida

Perrigo Company PLC (PRGO) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Perrigo Company plc|PRGO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Perrigo Company|PRGO - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Perrigo|PRGO - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati perrigo.com|PRGO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Perrigo Company plc|PRGO - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Perrigo Company|PRGO - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Perrigo Company
Kompaniyaning dastlabki tahlili:Perrigo Company plc - PRGO
Perrigo Company original mahsuloti

Aktivlarni stress-testdan o'tkazish uchun investor Market-to-Book ko'rsatkichini baholaydi, u biznesning qanchalik hadda qimmat yoki arzon baholanganini aniqlash uchun sof kapitaldan yuqori bo'lgan bozor premiumini o'lchaydi. Perrigo Company plc (PRGO) tomonidan retseptsiz dori vositalari va bolalar taomlarini keng miqyosda ulgurji taqsimot qilish kontekstida, bozor qiymatining balans qiymatiga nisbati dinamikasi ushbu biznes modelining samaradorligiga bo'lgan bozor ishonchining real vaqt rejimida bahosini taqdim etadi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati HLN|KVUE (kenvue.com) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Verona Pharma VRNA|Sof aktivlarga nisbatan bozor kapitallashuvi Jyong Biotech Limited|Ligand Pharma (LGND) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Amneal Corp (AMRX)|Bozor kapitallashuvining balans qiymatiga nisbati ALVO (Alvotech)|liquidia.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Galapagos (GLPG)|ANIP: Balans qiymatiga nisbatan bozor qiymati|MNKD (MannKind Corp.) - Bozor qiymatining balans qiymatiga nisbati|Amphastar Corp (AMPH) - Kapitallashuvning sof aktivlarga nisbati|PCRX (Pacira BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AQST (Aquestive Therapeutics Inc)|SCPH: Bozor qiymatining balans qiymatiga nisbati|TECX - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Tonix Pharmaceuticals TNXP|SXTC - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati EXOZ (Invizyne Technologies, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti ORMP|Entera Bio Ltd. (ENTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HYFT (ipatherapeutics.com)|ABVC BioPharma, Inc. (ABVC) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Cumberland Pharmaceuticals Inc CPIX|QNTM (Quantum BioPharma Limited) - Bozor kapitallashuvining balans qiymatiga nisbati|FGEN: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Telomir Pharmaceuticals TELO|RANI (Rani Therapeutics Holdings, Inc.) - Balans qiymatiga nisbatan bozor qiymati|SNYR - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Rallybio Corp.|LEXX (Lexaria Bioscience) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Pulmatrix Corporation (PULM)|PTHL (Pheton Holdings) - Bozor kapitallashuvining balans qiymatiga nisbati|Aptorum Group Ltd - Bozor qiymatining xususiy kapitalga nisbati|LYRA (Lyra Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|impactbiomedinc.com (IBO) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati tnfpharma.com TNFA|cbdMD (YCBD) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati PRFX|Kapitallashuvning sof aktivlarga nisbati CYTO|Lipella Pharmaceuticals, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti OPTN (OptiNose Inc)|Pieris - Bozor qiymatining balans qiymatiga nisbati|Procaps Group Corp - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati Petros Pharmaceuticals|QLI - Sof aktivlarga nisbatan bozor kapitallashuvi|SLRN: Bozor kapitallashuvining balans qiymatiga nisbati|TFFP (TFF Pharmaceuticals Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati